| Sector |
Healthcare
|
Compare with Sector peers |
| Industry |
Pharmaceuticals & Drugs
|
Compare with Industry peers |
| Website | http://www.lactoseindialimited.com | |
| Market Cap | 60.80 Cr. | |
| Enterprise Value(EV) | 101.35 Cr. | 2022-09 |
| Financial Indicators | ||
|---|---|---|
| Earnings per share (EPS) | 2.35 | Trailing Twelve Months Ending 2022-09 |
| Price-Earning Ratio (PE) | 20.55 | Trailing Twelve Months Ending 2022-09 |
| Industry PE | 32.90 | Trailing Twelve Months Ending 2022-09 |
| Book Value / Share | 31.34 | Trailing Twelve Months Ending 2022-09 |
| Price to Book Value | 1.54 | Calculated using Price: 48.30 |
| Dividend Yield | 0.00 | Period Ending 2022-03 |
| No. of Shares Subscribed | 1.26 Cr. | 12,589,000 Shares |
| FaceValue | 10 | |
| Company Profile | ||
| Lactose (India), a Toshniwal Group company, was incorporated in 1991, under the Companies Act, 1956. Its plant in Vadodara, Gujarat was commissioned by Alfa Laval, Pune (which is a subsidary of Alfa Laval of Sweden) and was also given a ‘thumbs up' by reputed dairy experts from the Netherlands in October 1991. Subsequently Alfa Laval, reputed dairy experts from Sweden and a joint commission from the Netherlands studied the plant and its working and confidently acknowledged the plant for its quality standards as well. | ||
| 1 Day |
|
-2.68% |
| 1 Week |
|
-2.10% |
| 1 Month |
|
-6.49% |
| 3 Month |
|
-29.06% |
| 6 Month |
|
-33.85% |
| 1 Year |
|
-6.41% |
| 2 Year |
|
+104.38% |
| 5 Year |
|
-64.53% |
| 10 Year |
|
+200.31% |
| 9 years | 2014-03 | 2015-03 | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | |
| Return on Equity (%) | 0.18 | 3.25 | 15.69 | 11.95 | -4.59 | 2.20 | 0.21 | -7.21 | 6.65 | |
| Return on Capital Employed (%) | 3.69 | 7.55 | 14.75 | 14.78 | 4.08 | 9.13 | 7.84 | 2.81 | 10.21 | |
| Return on Assets (%) | 0.05 | 0.71 | 3.44 | 3.30 | -1.59 | 0.88 | 0.09 | -2.88 | 2.75 |
| Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2022-09* Rs. Cr. |
| Shh. Funds | 15 | 16 | 20 | 27 | 32 | 34 | 34 | 35 | 39 | 39 | |
| Non Curr. Liab. | 30 | 44 | 37 | 31 | 38 | 35 | 38 | 42 | 36 | 36 | |
| Curr. Liab. | 16 | 20 | 26 | 27 | 13 | 12 | 11 | 12 | 15 | 13 | |
| Minority Int. | |||||||||||
| Equity & Liab. | 60 | 80 | 83 | 85 | 83 | 82 | 84 | 88 | 90 | 89 | |
| Non Curr. Assets | 47 | 67 | 66 | 68 | 66 | 64 | 64 | 69 | 67 | 65 | |
| Curr. Assets | 13 | 13 | 17 | 17 | 17 | 18 | 20 | 20 | 23 | 24 | |
| Misc. Exp. not W/O | |||||||||||
| Total Assets | 60 | 80 | 83 | 85 | 83 | 82 | 84 | 88 | 90 | 89 |
| Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2022-09 Rs. Cr. TTM |
| Net Sales | 22 | 24 | 34 | 36 | 31 | 41 | 40 | 35 | 46 | 49 | |
| Other Income | 1 | 0 | 1 | 1 | 1 | 0 | 0 | 0 | 1 | 1 | |
| Total Income | 23 | 24 | 36 | 37 | 32 | 41 | 40 | 35 | 47 | 50 | |
| Total Expenditure | -21 | -19 | -24 | -24 | -25 | -31 | -31 | -29 | -34 | -36 | |
| PBIDT | 2 | 5 | 12 | 12 | 6 | 10 | 10 | 7 | 13 | 14 | |
| Interest | -1 | -3 | -4 | -4 | -5 | -5 | -6 | -5 | -5 | -5 | |
| Depreciation | -2 | -2 | -3 | -3 | -4 | -4 | -4 | -4 | -5 | -5 | |
| Taxation | 0 | 0 | -1 | -2 | 1 | 0 | 0 | 1 | -1 | -1 | |
| Exceptional Items | 2 | ||||||||||
| PAT | 0 | 1 | 3 | 3 | -1 | 1 | 0 | -2 | 2 | 3 | |
| Adjusted EPS | 0 | 1 | 3 | 3 | -1 | 1 | 0 | -2 | 2 | 2 |
| Particulars | 10 years | 2013-03 Rs. Cr. | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. |
| Cash Fr. Operatn. | 14 | 7 | 13 | 1 | 8 | 0 | 5 | 7 | 2 | 8 | |
| Cash Fr. Inv. | -14 | -21 | -23 | 3 | -5 | -2 | -2 | -3 | -6 | -1 | |
| Cash Fr. Finan. | 1 | 13 | 10 | -5 | -3 | 4 | -5 | -4 | 5 | -8 | |
| Net Change | 1 | -1 | -1 | 0 | 0 | 3 | -2 | 1 | 1 | 0 | |
| Cash & Cash Eqvt | 1 | 1 | 0 | 0 | 0 | 3 | 1 | 2 | 2 | 2 |
|
Wed, 11 Jan 2023
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 This is to certify that the details of securities dematerialized during the quarter ended 31st December 2022 as required under Regulation 74(5) of SEBI (Depositories and Participants) Regulations 2018 have been furnished to BSE Limited where the shares of the Lactose (India) Limited are listed. The letter confirming this from our Registrar and Share Transfer Agent - Bigshare Services Private Limited dated 07th January 2023 is enclosed for your reference. |
|
Fri, 30 Dec 2022
Closure of Trading Window As per the Companys Code of Internal Procedures and Conduct for Regulating Monitoring and Reporting of Trading by Designated Person and their immediate Relatives of the Company read with SEBI (Prohibition of Insider Trading) Regulations 2015 trading window for dealing in securities of the Company will remain closed from Sunday 01st January 2023 till completion of 48 hours after Unaudited Financial Results for the Third quarter ended 31st December 2022 generally made available to public.In view of above all concerned person are advise not to deal (buy or sell) in Securities of Lactose (India) Limited during the said prohibited period Further the date of Board Meeting for consideration of the financial results of the Company for the Third quarter ended 31st December 2022 will be intimated in due course. |
|
Mon, 05 Dec 2022
Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011. The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 on December 05 2022 for Atul Maheshwari & Others |
| Fri, 27 Jan 2023 |
High Delivery Percentage
|
Higher Delivery Quantity
|
Higher Delivery Quantity and Percentage
|
Close Crossing Last Month Low
|
Opening at High
|
Equities
M.F.
Sectors